82 results
Page 2 of 5
20-F/A
wnft81rsx18d
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.5
eoinzz x4ihespfbbmf
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
5a50rkpiuku8v3wgkwb
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
m0anqi4
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
wc63f keo
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
e56gwmlte2
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
4eipmdwwbycwxbyu
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
j8k3kvy277 vsuy
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
ncbwfuobxbt z4p5y4
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
w4r 601ehlsd6ffosf6
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
igcjh
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
jc648n6t
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
4ib9uh
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
jygrus4o7y
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.2
g09m87y hg1c7qme
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
3wdge57bj
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
uf9ta
12 Jan 18
Annual report (foreign) (amended)
12:00am